XENTRIOR Trademark

Trademark Overview

On Thursday, July 6, 2006, a trademark application was filed for XENTRIOR with the United States Patent and Trademark Office. The USPTO has given the XENTRIOR trademark a serial number of 78923682. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Tuesday, July 5, 2011. This trademark is owned by Agouron Pharmaceuticals, Inc.. The XENTRIOR trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of cancer
xentrior

General Information

Serial Number78923682
Word MarkXENTRIOR
Filing DateThursday, July 6, 2006
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateTuesday, July 5, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 3, 2007

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 11, 2006
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAgouron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameAgouron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Wednesday, August 10, 2011UNDELIVERABLE MAIL - NO ACTION TAKEN
Tuesday, July 5, 2011ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Tuesday, July 5, 2011ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 7, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, December 6, 2010EXTENSION 5 GRANTED
Tuesday, November 30, 2010EXTENSION 5 FILED
Tuesday, November 30, 2010TEAS EXTENSION RECEIVED
Tuesday, May 25, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, May 24, 2010EXTENSION 4 GRANTED
Thursday, May 20, 2010EXTENSION 4 FILED
Thursday, May 20, 2010TEAS EXTENSION RECEIVED
Thursday, January 21, 2010EXTENSION 3 GRANTED
Thursday, December 3, 2009EXTENSION 3 FILED
Wednesday, January 20, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 3, 2009TEAS EXTENSION RECEIVED
Friday, June 5, 2009EXTENSION 2 GRANTED
Monday, June 1, 2009EXTENSION 2 FILED
Monday, June 1, 2009TEAS EXTENSION RECEIVED
Monday, December 1, 2008EXTENSION 1 GRANTED
Tuesday, November 25, 2008EXTENSION 1 FILED
Monday, December 1, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 25, 2008TEAS EXTENSION RECEIVED
Tuesday, June 3, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 21, 2008TTAB RELEASE CASE TO TRADEMARKS
Monday, April 21, 2008OPPOSITION TERMINATED NO. 999999
Monday, April 21, 2008OPPOSITION DISMISSED NO. 999999
Wednesday, January 9, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 2, 2007OPPOSITION INSTITUTED NO. 999999
Thursday, April 26, 2007EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, April 3, 2007PUBLISHED FOR OPPOSITION
Wednesday, March 14, 2007NOTICE OF PUBLICATION
Thursday, February 15, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, February 15, 2007ASSIGNED TO LIE
Thursday, January 11, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 10, 2007EXAMINERS AMENDMENT MAILED
Tuesday, January 9, 2007EXAMINER'S AMENDMENT ENTERED
Tuesday, January 9, 2007EXAMINERS AMENDMENT -WRITTEN
Friday, December 8, 2006PRIORITY ACTION MAILED
Friday, December 8, 2006PRIORITY ACTION WRITTEN
Wednesday, December 6, 2006ASSIGNED TO EXAMINER
Tuesday, July 11, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

xentrior cancer treatment preparations pharmaceutical